Loading...

iSpecimen Inc.

ISPC•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.07
$-0.03(-2.73%)

iSpecimen Inc. (ISPC) Stock Overview

Explore iSpecimen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 59.1/100

Key Financials

Market Cap2.7M
P/E Ratio-0.22
EPS (TTM)$-11.93
ROE-2.85%
Fundamental Analysis

AI Price Forecasts

1 Week$1.23
1 Month$-0.72
3 Months$0.00
1 Year Target$1.55

ISPC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iSpecimen Inc. (ISPC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.22 and a market capitalization of 2.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;